# Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals

> **NCT00249483** · PHASE2 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 150 (actual)

## Conditions studied

- Cocaine-Related Disorders

## Interventions

- **DRUG:** Venlafaxine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00249483
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2005-02
- **Final completion:** 2005-02
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2017-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00249483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00249483, "Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00249483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*